Skip to content
OpenCapital
Get started

OraSure Technologies OSUR Total investments

Total investments at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$68.09M—

Other financials

Income statement

See full
Revenue$27.9M-6.7%
Gross profit$11.8M-4.0%
Operating income-$23.3M-31.1%
Net income-$22.4M-39.5%
EPS (diluted)-$0.32-52.4%

Balance sheet

See full
Cash & equivalents$177.0M-28.5%
Total debt$12.7M-10.9%
Total equity$313.3M-20.9%
Total assets$379.2M-17.1%

Cash flow

See full
Operating cash flow-$13.9M+29.6%
CapEx$913.0K+117%
Free cash flow-$14.8M+26.5%

Valuation

See full
Market cap$303.62M+35.3%
Enterprise value$139.32M-1,654%
P/S2.7×+1.3×

Profitability

See full
Gross margin42.2%+0.4pp
Operating margin-68.6%-149pp
Net margin-66.4%-115pp
FCF margin-42.4%-43.3pp

Returns & leverage

See full
Return on equity-21.2%-50.4pp
Debt / equity0×0.0×
Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFVNINoncurrent.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's total investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OraSure Technologies's total investments?
OraSure Technologies (OSUR) reported total investments of $24.87M in Q1 2026.
How has OraSure Technologies's total investments changed year-over-year?
OraSure Technologies's total investments decreased by 10.5% year-over-year, from $27.78M to $24.87M.
What does total investments mean?
This metric represents the aggregate value of all long-term financial assets held by the company, including marketable securities, debt instruments, and other investment vehicles. It reflects the company's strategy for deploying excess capital to generate returns outside of core operational activities. Monitoring this balance helps investors assess the liquidity and risk profile of the company's non-operating asset portfolio.